9-135664247-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001393661.1(LCN9):c.182G>A(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,613,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001393661.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN9 | NM_001393661.1 | c.182G>A | p.Arg61Gln | missense_variant | 2/6 | ENST00000619315.2 | NP_001380590.1 | |
LCN9 | NR_171893.1 | n.195G>A | non_coding_transcript_exon_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN9 | ENST00000619315.2 | c.182G>A | p.Arg61Gln | missense_variant | 2/6 | 1 | NM_001393661.1 | ENSP00000482296 | P1 | |
LCN9 | ENST00000430290.6 | n.168G>A | non_coding_transcript_exon_variant | 2/6 | 5 | |||||
LCN9 | ENST00000277526.8 | c.182G>A | p.Arg61Gln | missense_variant, NMD_transcript_variant | 2/6 | 5 | ENSP00000277526 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249254Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135228
GnomAD4 exome AF: 0.0000766 AC: 112AN: 1461580Hom.: 0 Cov.: 35 AF XY: 0.0000674 AC XY: 49AN XY: 727102
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.182G>A (p.R61Q) alteration is located in exon 2 (coding exon 2) of the LCN9 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at